Task area 2: regulatory support for IND and IDE submissions

Ended Awarded Last action

Contract number
75N92022F00002
Awardee
Awarding agency
Obligated
$97,027

Award facts

Contract value 100% obligated
$97,026.88 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Time and Materials
Place of performance
Rockville, MD 20850, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00002 -$24,625
Definitize Change Order P00001 $50,395
Original award $71,257

About this award

The National Heart Lung and Blood Institute issued a delivery order to The Emmes Company, LLC on July 1, 2022, with a ceiling value of $97,026.88 for regulatory support for Investigational New Drug and Investigational Device Exemption submissions under Task Area 2.

Place of performance is Rockville, MD. The order is priced on a time-and-materials basis with an ultimate completion date of June 30, 2023. No set-aside was used.

Quick answers

Who was awarded contract 75N92022F00002?

75N92022F00002 was awarded to The Emmes Company, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2022.

How much is contract 75N92022F00002 worth?

The government has obligated $97,027 on 75N92022F00002.

Is contract 75N92022F00002 an order under another contract?

Yes. 75N92022F00002 is a delivery order under 75N92020D00017, an indefinite delivery contract.

Was contract 75N92022F00002 competed?

The extent of competition for 75N92022F00002 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award